The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $5,002.83 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 68 mg NEXPLANON implants, a contraceptive medication, with a completion date of January 9, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which covers a comprehensive range of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains.
Generated 3/18/25, 9:54 AM